Enzoflam SV Tablet is a combination pharmaceutical formulation containing Bromelain 90 mg, Trypsin 48 mg, and Rutoside 100 mg, designed to provide anti-inflammatory, proteolytic, and vasoprotective effects. Bromelain, a proteolytic enzyme derived from pineapple stems, facilitates the breakdown of proteins and exhibits potent anti-inflammatory and analgesic properties, making it effective in reducing edema and promoting tissue healing. Trypsin, another proteolytic enzyme, synergistically enhances the degradation of inflammatory mediators and fibrin, thereby aiding in the resolution of inflammation and improving wound healing processes. Rutoside, a bioflavonoid, contributes to the stabilization of capillary walls, reducing capillary permeability and fragility, which helps in minimizing bruising and edema associated with inflammatory conditions. The combined action of these active ingredients makes Enzoflam SV particularly useful in the management of acute and chronic inflammatory disorders, including post-traumatic swelling, postoperative edema, and musculoskeletal injuries. It is also employed as an adjunct therapy in vascular disorders characterized by capillary fragility. Enzoflam SV should be used under medical supervision, with consideration of contraindications such as hypersensitivity to any component, active bleeding disorders, or concurrent use of anticoagulants. Proper dosage and duration of therapy should be adhered to for optimal therapeutic outcomes.